I LEO GLASSER, Senior District Judge.
Plaintiff Dukes Bridge LLC ("Dukes Bridge") brings this action against Security Life of Denver Insurance Company ("SLD") to obtain payment of death benefits on a life insurance policy that SLD issued. SLD raises an affirmative defense of fraud and asserts counterclaims against Dukes Bridge and numerous other individuals and entities, including Central Strategies, LLC ("CS"), Moshe Schreiber, and Grecia Scibilia (together, the "CS counterclaim defendants"). SLD alleges that Dukes Bridge and the other counterclaim defendants are endeavoring to defraud SLD as part of a "strangeroriginated life insurance," or "STOLI," scheme, in which persons with no insurable interest in an individual's life illegally obtain an interest in a life insurance policy on that individual, essentially betting on his or her demise.
Except where otherwise noted, the following facts are taken from the Second Amended Counterclaim (Dkt. No. 109) and are accepted as true for the purpose of deciding this motion. Because SLD makes extensive allegations regarding the conduct of multiple parties, the Court's recitation of the facts here is limited to those that concern the claims against the CS counterclaim defendants. SLD is a Colorado company that underwrites life insurance policies, including those for ING Life Companies ("ING"). CS is a New York company that markets and sells life insurance policies on the secondary market. At all times relevant to this litigation, Schreiber was an insurance broker and owner of CS. Scibilia was a CS employee. SLD asserts, and the CS counterclaim defendants do not dispute, that this court has jurisdiction over the counterclaims pursuant to 28 U.S.C. § 1332(a)(1), and that venue is proper.
In the fall of 2007, CS entered into a series of agreements with Joseph Rubin, another insurance broker and proprietor of his own company, Joseph Rubin Inc., by which they planned to share between them commissions to be earned on life insurance policies they procured for a man named Eugene Mermelstein. Rubin and the CS counterclaim defendants approached the Bollinger Group ("Bollinger"), an agency that facilitates communication between brokers and insurance companies, in early September of 2007 to discuss obtaining policies on Mermelstein's life. On September 15, 2007, Bollinger submitted a preliminary inquiry to ING, and ING responded that it would be willing to consider issuing a policy on his life, subject to the submission of a formal application that met all underwriting requirements.
In October of 2007, a number of trusts were created by Mermelstein, naming Mermelstein as the grantor and various members of his family as trustees. One of these trusts, the E. Mermelstein Irr Trust A ("Trust A"), named Mermelstein's daughter, Esther Fried, as both its sole trustee and beneficiary. On or about October 23, 2007, Mermelstein and Fried signed an application for a $10,000,000.00 life insurance policy from ING to be underwritten by SLD (the "Policy"). The application named Mermelstein as the proposed life to be insured, Trust A as the beneficiary, and New Jersey as the state from which the application originated and insurance would issue. In support of that application, Mermelstein and Fried affirmed that Mermelstein's total net worth was $20,000,000.00 and that his annual personal income was $1,300,000.00. Rubin completed a portion of the application, indicating that he was Mermelstein's insurance agent, and that, to his knowledge, Trust A did not intend to transfer ownership of the Policy or seek financing for its premiums. Rubin's office forwarded Rubin's portion of the application to Scibilia, who directed Rubin to leave blank a question which asked whether Mermelstein was applying for other life insurance policies, which Rubin did. Scibilia then forwarded the signed application to Bollinger, who in turn forwarded it to SLD.
SLD asked for further details about Mermelstein, including information about other insurance he carried (if any) and confirmation of the health and financial information contained in his application. After receiving this request, Rubin and the CS counterclaim defendants directed Jewel Strader, a co-counterclaim-defendant based in Texas, to prepare an "Inspection Report" that purported to contain the requested information. The Inspection Report provided independent third-party verification of Mermelstein's health and income. It noted, among other things, that Mermelstein had no other insurance in force, and that Mermelstein's accountant had stated that Mermelstein's annual income was over $1,000,000.00 and his total net worth was approximately $30,000,000.00. The CS counterclaim defendants and Rubin also told Bollinger that while Mermelstein was applying to two other insurers for coverage, he would only accept the carrier who made the best offer.
In January of 2008, relying on the above submissions, SLD approved Mermelstein's application and issued the $10,000,000.00 Policy, which required an initial premium of $872,300.00. That premium was paid by check and wire transfer. The submissions SLD relied upon in approving the application, however, were fraudulent. Mermelstein's income was not over $1,000,000.00 a year, his net worth was not $20,000,000.00 or more, the accountant and other companies referenced in the Inspection Report were fictitious, outside financing had been secured to pay the Policy's premiums, Fried (on behalf of Trust A) had always intended to transfer the Policy to others, and Rubin and the CS counterclaim defendants had obtained or were in the process of obtaining similar life insurance policies on Mermelstein from other companies. Schreiber was paid $252,967.00 of the $305,305.00 commission that Bollinger received from SLD for obtaining the Policy. Had SLD known of the deception described above, it would not have issued the Policy.
A complex web of shell trusts and financing organizations making loans to one another paid the premiums on the Policy, but SLD claims the party responsible for making these payments was Dukes Bridge, the plaintiff in this action. After Mermelstein died in 2009, Dukes Bridge, which had become the ultimate owner of the Policy by virtue of a chain of reassignments, requested the Policy's proceeds. SLD refused to pay, prompting Dukes Bridge to file this suit on November 29, 2010.
To survive a motion to dismiss under Federal Rule of Civil Procedure 12(b)(6), a complaint (or, in this case, counterclaim) must contain "sufficient factual matter, accepted as true, to `state a claim to relief that is plausible on its face.'"
Additionally, when a party alleges fraud or mistake, it must "state with particularity the circumstances constituting [such] fraud or mistake" in its pleading. Fed. R. Civ. P. 9(b). To satisfy this particularity requirement, a pleading must "`adequately specify the statements it claims were false or misleading, give particulars as to the respect in which plaintiff contends the statements were fraudulent, state when and where the statements were made, and identify those responsible for the statements.'"
Count I of the Second Amended Counterclaim, which seeks rescission of the Policy on grounds of fraud, is not asserted against the CS counterclaim defendants. Count II is a common law claim for fraud. Count III pleads knowing or negligent material misrepresentations of fact. Count IV alleges that the counterclaim defendants "lack[ed] [an] insurable interest" in Mermelstein's life. Count V alleges violations of the New Jersey Insurance Fraud Prevention Act ("NJIFPA"), N.J. Stat. Ann. § 17:33A-1,
"A federal court, sitting in diversity, must look to the choice-of-law rules of the state in which it sits—here New York—to resolve conflict-of-law questions."
At this juncture, the CS counterclaim defendants are estopped from arguing that they cannot be bound to the Policy's choice-of-law clause by virtue of the fact that they did not sign the Policy because SLD alleges that they derived a direct benefit from it.
"Under New York choice-of-law rules, `[t]he first step . . . is to determine whether there is an actual conflict between the laws of the jurisdictions involved.'"
When resolving conflicts of law over tort claims, New York courts conduct an "interest analysis," which is "a `flexible approach intended to give controlling effect to the law of the jurisdiction which, because of its relationship or contact with the occurrence or the parties, has the greatest concern with the specific issue raised in the litigation.'"
The CS counterclaim defendants argue that New York law should govern this dispute because the alleged actions they took to orchestrate the sale of the Policy occurred in New York, where Mermelstein lived. SLD, however, correctly points out that a rider attached to the Policy states that "[a]ll communications, solicitation, and negotiation [for its] application occurred in the Application State [
To state a claim for common law fraud in New Jersey, plaintiffs must allege (1) a material misrepresentation of a presently existing or past fact, (2) the defendant's knowledge or belief of its falsity, (3) an intention that the recipient of the misrepresentation will rely on it, (4) reasonable reliance thereon by that recipient, and (5) resulting damages.
To the extent that Count III alleges a "knowing" material misrepresentation of fact, it is duplicative of Count II.
At oral argument on this motion, SLD agreed to discontinue pursuing Count IV as against the CS counterclaim defendants, and it is dismissed accordingly.
Since SLD's common law fraud claim survives the motion to dismiss, its claim under the NJIFPA also survives "because this type of claim requires much less thorough pleading."
"In New Jersey, a civil conspiracy is `a combination of two or more persons acting in concert to commit an unlawful act, or to commit a lawful act by unlawful means, the principal element of which is an agreement between the parties to inflict a wrong against or injury upon another, and an overt act that results in damage.'"
All remaining counts of the Second Amended Counterclaim allege fraud, thereby triggering the "particularity" requirement of Rule 9(b). Additionally, Counts II and VI allege intent to defraud, and while Rule 9(b) notes that intent may be averred generally in a complaint, "plaintiffs are still required to plead the factual basis which gives rise to a `strong inference' of fraudulent intent."
The CS counterclaim defendants argue that the remaining counts fail to meet the above requirements because (1) their underlying factual allegations are based largely upon information and belief, (2) the facts pleaded do not give rise to a strong inference of fraudulent intent, and (3) the allegations fail to specify which counterclaim defendant was responsible for each individual alleged misrepresentation. These arguments are meritless, for the reasons set forth below.
Ordinarily, "Rule 9(b) pleadings cannot be based upon information and belief."
A strong inference of fraudulent intent may be established "either (a) by alleging facts to show that defendants had both motive and opportunity to commit fraud, or (b) by alleging facts that constitute strong circumstantial evidence of conscious misbehavior or recklessness."
Finally, the CS counterclaim defendants claim that the language in the counts themselves violates Rule 9(b) because it does not describe which counterclaim defendants are responsible for which allegedly unlawful actions. The pleading as a whole, however, describes each counterclaim defendant's distinct role in the STOLI scheme: the CS counterclaim defendants coordinated with Rubin to effectuate the sale of the Policy, Strader drafted the fraudulent Inspection Report, Fried co-signed the Policy with her father for Trust A before leaving the trust in the hands of strangers, and Dukes Bridge and its affiliates ultimately attempted to claim the benefits. In other words, while the various counterclaim defendants played different parts in the scheme, all of them committed fraud. One of the central purposes of Rule 9(b) is to "provide a defendant with fair notice of a plaintiff's claim," and that notice need not take any specific form so long as it is sufficiently particularized.
For the foregoing reasons, the CS counterclaim defendants' motion to dismiss the Second Amended Counterclaim as against them is GRANTED solely as to Counts III and IV and otherwise DENIED.
SO ORDERED.